In this context, we hypothesised that bFGF could modulate the gene expression profile of subcutaneous and visceral ASCs from individuals with obesity and type 2 diabetes to restore the stem cell function impaired by diabetes and promote microvascular vessel formation, stabilisation and maturation, thereby ameliorating vascular dysfunction associated with excess fat accumulation. This evidence concerns the gene FGF2 and type 2 diabetes mellitus.